(Q43250306)

17 November 2017

title

Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation (English)

1 reference

positron emission tomography

17 November 2017

main subject

1 reference

1 reference

Andrea Gallamini

1

1 reference

17 November 2017

Francesca Fiore

series ordinal

2

1 reference

17 November 2017

Roberto Sorasio

series ordinal

3

1 reference

17 November 2017

Michel Meignan

series ordinal

4

1 reference

17 November 2017

publication date

1 November 2009

1 reference

17 November 2017

1 reference

17 November 2017

volume

50

1 reference

17 November 2017

issue

11

1 reference

17 November 2017

page(s)

1761-1764

1 reference

The disappearance of prognostic factors in Hodgkin's disease

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

Comparison of prognostic models in patients with advanced Hodgkin disease. Promising results from integration of the best three systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

PET/CT for therapy response assessment in lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

The role of cytokines in classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

Overview of early response assessment in lymphoma with FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

Early prediction of response to therapy: the clinical implications in Hodgkin's and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

[(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

Early interim PET scan in Hodgkin lymphoma: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308072

10.3109/10428190903308072

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference